DE HB339 | 2019-2020 | 150th General Assembly
Status
Spectrum: Bipartisan Bill
Status: Introduced on June 16 2020 - 25% progression, died in committee
Action: 2020-06-16 - Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House
Pending: House Economic Development/Banking/Insurance & Commerce Committee
Text: Latest bill text (Draft #1) [HTML]
Status: Introduced on June 16 2020 - 25% progression, died in committee
Action: 2020-06-16 - Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House
Pending: House Economic Development/Banking/Insurance & Commerce Committee
Text: Latest bill text (Draft #1) [HTML]
Summary
Over 80% of pharmaceuticals in the United States are purchased through pharmacy benefits manager (PBM) networks. PBMs serve as intermediaries between health plans, pharmaceutical manufacturers and pharmacies, and PBMs establish networks for consumers to receive reimbursement for drugs. Given the scope of PBMs in the healthcare delivery system, this Act is designed to provide enhanced oversight and transparency as it relates to PBMs.
Title
An Act To Amend Title 18 Of The Delaware Code Relating To Pharmacy Benefits Managers.
Sponsors
History
Date | Chamber | Action |
---|---|---|
2020-06-16 | Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House |